This study is something to keep in mind when we evaluate neonatal outcomes in mothers taking psychotropic medication. We typically consider maternal, but not paternal, characteristics as factors which may affect neonatal outcomes; however, this [...]
The newer “atypical” or second-generation antipsychotic agents are now used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders. The National Pregnancy Registry for Atypical Antipsychotics [...]
For clinicians who have not yet discovered the incredibly thoughtful and clinically practical monthly articles from Chittaranjan Andrade in the Journal of Clinical Psychiatry, it’s time to take a look. (Not only are these articles [...]
A history of maternal psychiatric illness has been linked to postpartum depression (PPD), but this does not account for all instances of postpartum psychiatric illness. A recent study examined the impact of medical complications during [...]
Serotonin reuptake inhibitor (SRI) antidepressants may affect platelet aggregation and thus may increase the risk of bleeding. Over the last few years, we have seen several studies which have sought to determine if exposure [...]
It is fairly well-known that interactions between parents and children are associated with improved developmental outcomes in children. Previous research has primarily focused on how maternal rather than paternal involvement influences infant neurodevelopment. A recent [...]
When we provide consultations regarding the use of antidepressants during pregnancy, one of the most difficult questions we have to answer is related to the long-term effects of prenatal antidepressant exposure. Specifically, do antidepressants [...]
Early pregnancy loss (EPL) is common, affecting up to 25% of pregnancies. Studies looking at the emotional consequences of miscarriage have shown that most women do well; however, some women experience clinically significant symptoms of [...]
When we meet women for consultations regarding the use of psychotropic medications during pregnancy, we focus primarily on the impact of medications on the developing fetus and the pregnancy. However, we need also to address [...]
Over the last few years, we have reported on several studies which have suggested an increased risk of certain types of cardiovascular malformations among children exposed to selective serotonin reuptake inhibitors (SSRIs) during pregnancy. The first reports [...]
